Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
7
Mins
21 Jul 2022
Review of the European Hematology Association 2022 Hybrid Congress
THE EUROPEAN Hematology Association (EHA) successfully brought together clinicians and researchers from all over the world to share the latest advances in the field of haematology in its 27th Annual Congress, and its first ever hybrid congress.
4
Mins
21 Jul 2022
Paediatric Von Willebrand Disease-Associated Angiodysplasia
Von Willebrand disease (VWD) was first described in 1926 by Erik von Willebrand when he cared for a family member…
4
Mins
21 Jul 2022
The Impact of Hormone Therapy on Venous Thromboembolism Risk in Women
MILLIONS of women across the world opt for hormone-based therapies for contraception, and as a replacement therapy for relieving symptoms…
31 May 2022
Novel targets for therapy in TD β-Thalassaemia
The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…
25 May 2022
CME-Accredited Webinar on Biosimilars within Haematology & Oncology
This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
13 May 2022
Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
12 May 2022
Study Uncovers Mechanisms of COVID-19-Mediated Platelet Activation
A pivotal study has uncovered the mechanisms behind the hyperactivation of platelets during a SARS-CoV-2 infection…
12 May 2022
EMA Recommends Gene Therapy for Treatment of Multiple Myeloma
Innovative personalised gene therapy for the treatment of multiple myeloma has been recommended by EMA. Read to find out more…
Loading posts...
« Previous
1
…
57
58
59
60
61
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View